Justin Kline

9.2k total citations · 2 hit papers
146 papers, 5.5k citations indexed

About

Justin Kline is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Justin Kline has authored 146 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Oncology, 65 papers in Immunology and 46 papers in Hematology. Recurrent topics in Justin Kline's work include CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (41 papers) and Lymphoma Diagnosis and Treatment (39 papers). Justin Kline is often cited by papers focused on CAR-T cell therapy research (41 papers), Immune Cell Function and Interaction (41 papers) and Lymphoma Diagnosis and Treatment (39 papers). Justin Kline collaborates with scholars based in United States, France and Canada. Justin Kline's co-authors include Thomas F. Gajewski, Aalok Kacha, Mercedes B. Fuertes, Thomas F. Gajewski, Long Zhang, Seng‐Ryong Woo, Kenneth M. Murphy, David M. Kranz, James Godfrey and Xiufen Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

Justin Kline

138 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells

2011 937 citations Aalok Kacha, Justin Kline et al. profile →
CD47 blockade triggers T cell–mediated destruction of immunogenic tumors

2015 611 citations Justin Kline et al. profile →

Peers

Countries citing papers authored by Justin Kline

Since Specialization

Citations

This map shows the geographic impact of Justin Kline's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Justin Kline with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Justin Kline more than expected).

Fields of papers citing papers by Justin Kline

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Justin Kline. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Justin Kline. The network helps show where Justin Kline may publish in the future.

Co-authorship network of co-authors of Justin Kline

This figure shows the co-authorship network connecting the top 25 collaborators of Justin Kline. A scholar is included among the top collaborators of Justin Kline based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Justin Kline. Justin Kline is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Two-stage CD8+ CAR T-cell differentiation in patients with large B-cell lymphoma 2025 ·Nature Communications ·Guoshuai Cao, (unknown), (unknown), Erting Tang, (unknown), (unknown), Jun Wan, Peter A. Riedell, Michael R. Bishop, Justin Kline, Jun Huang	2
2	Targeting PRDM1 to Enhance CAR T Cell Therapy Against Diffuse Large B Cell Lymphoma (DLBCL) 2024 ·Blood ·Sidney Wang, Lishi Xie, Xiufen Chen, Alan Cooper, (unknown), Justin Kline	1
3	T-cell States, Repertoire, and Function in Classical Hodgkin Lymphoma Revealed through Single-Cell Analyses 2024 ·Cancer Immunology Research ·Xiufen Chen, Jovian Yu, Girish Venkataraman, Sonali M. Smith, Mengjie Chen, Alan Cooper, (unknown), Joshua Brody, James Godfrey, Justin Kline	1
4	CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition 2023 ·Journal of Clinical Oncology ·Alan Cooper, (unknown), (unknown), Girish Venkataraman, Joo Y. Song, Andrew Lytle, Gerben Duns, Jovian Yu, Nikita Kotlov, Alexander Bagaev, Brendan P. Hodkinson, Srimathi Srinivasan, Sonali M. Smith, David W. Scott, Christian Steidl, James Godfrey, Justin Kline	10
5	Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up 2023 ·Blood Advances ·Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta–Shah, Julie Lisano, (unknown), (unknown), Alison J. Moskowitz	18
6	TIGIT is a key inhibitory checkpoint receptor in lymphoma 2023 ·Journal for ImmunoTherapy of Cancer ·James Godfrey, Xiufen Chen, Nicole Sunseri, Alan Cooper, Jovian Yu, (unknown), Dmitry N. Zarubin, (unknown), Connor A. Jacobson, Ekaterina Postovalova, Zhongmin Xiang, Krystle Nomie, Alexander Bagaev, Girish Venkataraman, Yuanyuan Zha, (unknown), Sonali M. Smith, Justin Kline	13
7	Eltrombopag Is a Safe and Effective Agent to Treat Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) 2023 ·Transplantation and Cellular Therapy ·He Gong, Theodore Karrison, Wendy Stock, Richard A. Larson, Satyajit Kosuri, James L. LaBelle, Justin Kline, Peter A. Riedell, (unknown), Michael R. Bishop, Hongtao Liu	0
8	A CD5 Gene Signature Identifies Diffuse Large B-Cell Lymphomas Sensitive to Brutonʼs Tyrosine Kinase Inhibition 2023 ·Blood ·Alan Cooper, (unknown), (unknown), Girish Venkataraman, Joo Y. Song, (unknown), Gerben Duns, Jovian Yu, Nikita Kotlov, Alexander Bagaev, Brendan P. Hodkinson, (unknown), Sonali M. Smith, David W. Scott, Christian Steidl, James Godfrey, Justin Kline	2
9	Pembrolizumab for patients with non-Hodgkin lymphoma: phase 1b KEYNOTE-013 study 2022 ·Leukemia & lymphoma ·John Kuruvilla, Philippe Armand, Mehdi Hamadani, Justin Kline, Craig H. Moskowitz, David Avigan, Joshua Brody, Vincent Ribrag, Alex F. Herrera, Franck Morschhauser, Abraham S. Kanate, Pier Luigi Zinzani, Jacob D. Bitran, Hervé Ghesquières, Stephen J. Schuster, Mohammed Z.H. Farooqui, Patricia Marinello, Nancy L. Bartlett	12
10	Impact of Pre-Treatment Whole-Body Metabolic Tumor Volume on Toxicities and Outcomes in Patients Treated with Anti-CD19 CAR T-Cell Therapy for Aggressive Large B-Cell NHL 2021 ·Transplantation and Cellular Therapy ·Alexandra E. Rojek, Justin Kline, Daniel Appelbaum, Yonglin Pu, (unknown), Benjamin A. Derman, Andrzej Jakubowiak, Satyajit Kosuri, Hongtao Liu, Michael R. Bishop, Peter A. Riedell	1
11	Acute myeloid leukemia cell membrane-coated nanoparticles for cancer vaccination immunotherapy 2021 ·Leukemia ·D. T. Johnson, Jiarong Zhou, Ashley V. Kroll, Ronnie H. Fang, Ming Yan, (unknown), Xiufen Chen, Justin Kline, Liangfang Zhang, Dong‐Er Zhang	64
12	Oxidized Lipoproteins Promote Resistance to Cancer Immunotherapy Independent of Patient Obesity 2020 ·Cancer Immunology Research ·(unknown), (unknown), (unknown), Maureen J. Donlin, Eddy C. Hsueh, Theresa Schwartz, (unknown), John M. Richart, (unknown), Amelia K. Pinto, Sarah L. George, (unknown), David A. Ford, Xiufen Chen, Justin Kline, Ryan M. Teague	26
13	Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma 2020 ·Journal for ImmunoTherapy of Cancer ·Sattva S. Neelapu, Sherry Adkins, Stephen M. Ansell, Joshua Brody, Mitchell S. Cairo, Jonathan W. Friedberg, Justin Kline, Ronald Levy, David L. Porter, Koen van Besien, Michael E. Werner, Michael R. Bishop	11
14	Macrophage Activation By Dual PI3K-δ/γ Inhibition Enhances Anti-CD47-Mediated Phagocytosis and Prolongs Survival in DLBCL 2020 ·Blood ·James Godfrey, Wenjun Kang, Lei Huang, Sílvia Coma, Roy L. Maute, Mark P. Chao, Jonathan A. Pachter, Sonali M. Smith, Justin Kline	4
15	Validation of Pre-Transplant Biomarker Measurement and Risk Score for Non-Relapse Mortality after Allogeneic Hematopoietic Cell Transplant (HCT) 2017 ·Blood ·(unknown), Lucy A. Godley, Justin Kline, Richard A. Larson, Hongtao Liu, Olatoyosi Odenike, Wendy Stock, Michael R. Bishop, Andrew Artz	1
16	AML1/ETO and FLT3-ITD Cooperate to Induce Acute Myeloid Leukemia in Mice 2017 ·Blood ·Xiufen Chen, Girish Venkataraman, Justin Kline	1
17	Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia 2017 ·Biology of Blood and Marrow Transplantation ·Jingmei Hsu, Andrew Artz, Sebastian Mayer, (unknown), Michael R. Bishop, Ronit Reich‐Slotky, Sonali M. Smith, (unknown), Justin Kline, (unknown), Adrienne A. Phillips, Usama Gergis, Hongtao Liu, Wendy Stock, Melissa M. Cushing, Tsiporah B. Shore, Koen van Besien	15
18	CD40 ligation reverses T cell tolerance in acute myeloid leukemia 2013 ·Journal of Clinical Investigation ·Long Zhang, Xiufen Chen, Xiao Liu, Douglas E. Kline, Ryan M. Teague, Thomas F. Gajewski, Justin Kline	58
19	Homeostatic Proliferation Plus Regulatory T-Cell Depletion Promotes Potent Rejection of B16 Melanoma 2008 ·Clinical Cancer Research ·Justin Kline, Ian E. Brown, (unknown), Christian U. Blank, John H. Strickler, (unknown), Long Zhang, Thomas F. Gajewski	79
20	Homeostatic Proliferation as an Isolated Variable Reverses CD8+ T Cell Anergy and Promotes Tumor Rejection 2006 ·The Journal of Immunology ·Ian E. Brown, Christian U. Blank, Justin Kline, Aalok Kacha, Thomas F. Gajewski	72

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact